Establishment of a UK National Influenza H5 Laboratory Network
- PMID: 17893159
- DOI: 10.1099/jmm.0.47336-0
Establishment of a UK National Influenza H5 Laboratory Network
Abstract
Avian (H5N1) influenza continues to pose a significant threat to human health, although it remains a zoonotic infection. Sensitive and robust surveillance measures are required to detect any evidence that the virus has acquired the ability to transmit between humans and emerge as the next pandemic strain. An integral part of the pandemic planning response in the UK was the creation in 2005 of the UK National H5 Laboratory Network, capable of rapidly and accurately identifying potential human H5N1 infections in all regions of the UK, and the Republic of Ireland. This review details the challenges that designing molecular detection methods for a rapidly evolving virus present, and the strategic decisions and choices required to ensure successful establishment of a functional national laboratory network, providing round the clock testing for H5N1. Laboratory partnerships have delivered improved real-time one-step multiplex PCR methodologies to ensure streamlined testing capable of not only detecting H5 but also a differential diagnosis of seasonal influenza A/B. A range of fully validated real-time PCR H5 confirmatory assays have been developed to run in parallel with a universal first-screening assay. Regular proficiency panels together with weekly surveillance runs, intermittent on-call testing for suspect cases of avian flu in returning travellers, and several outbreaks of avian influenza outbreaks in poultry that have occurred since 2005 in the UK have fully tested the network and the current diagnostic strategies for avian influenza. The network has clearly demonstrated its capability of delivering a confirmed H5N1 diagnosis within 3-4 h of receipt of a sample, an essential prerequisite for administration of the appropriate antiviral therapy, effective clinical management, disease containment and implementation of infection control measures. A functional network is an important means of enhancing laboratory capability and building diagnostic capacity for a newly emerging pandemic of influenza, and is an essential part of pandemic preparedness.
Similar articles
-
Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans.J Clin Microbiol. 2007 May;45(5):1535-43. doi: 10.1128/JCM.02007-06. Epub 2007 Mar 14. J Clin Microbiol. 2007. PMID: 17473050 Free PMC article.
-
Laboratory investigation of the first suspected human cases of infection with avian influenza A(H5N1) virus in Bulgaria.Euro Surveill. 2008 Jul 24;13(30):18938. Euro Surveill. 2008. PMID: 18761909
-
Development and validation of a commercial real-time NASBA assay for the rapid confirmation of influenza A H5N1 virus in clinical samples.J Virol Methods. 2010 Dec;170(1-2):173-6. doi: 10.1016/j.jviromet.2010.09.014. Epub 2010 Sep 21. J Virol Methods. 2010. PMID: 20863852
-
The evolving threat of influenza viruses of animal origin and the challenges in developing appropriate diagnostics.Clin Chem. 2012 Nov;58(11):1527-33. doi: 10.1373/clinchem.2012.182626. Epub 2012 Sep 11. Clin Chem. 2012. PMID: 22968105 Review.
-
The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses.Viruses. 2018 Aug 28;10(9):461. doi: 10.3390/v10090461. Viruses. 2018. PMID: 30154345 Free PMC article. Review.
Cited by
-
Establishing a laboratory network of influenza diagnosis in Indonesia: an experience from the avian flu (H5N1) outbreak.Clin Epidemiol. 2012;4:209-12. doi: 10.2147/CLEP.S31004. Epub 2012 Aug 15. Clin Epidemiol. 2012. PMID: 22936856 Free PMC article.
-
PrimerHunter: a primer design tool for PCR-based virus subtype identification.Nucleic Acids Res. 2009 May;37(8):2483-92. doi: 10.1093/nar/gkp073. Epub 2009 Mar 5. Nucleic Acids Res. 2009. PMID: 19264805 Free PMC article.
-
Avian influenza--a review for doctors in travel medicine.Travel Med Infect Dis. 2010 Jan;8(1):1-12. doi: 10.1016/j.tmaid.2009.11.006. Epub 2009 Dec 1. Travel Med Infect Dis. 2010. PMID: 20188299 Free PMC article. Review.
-
Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England.J Infect Dis. 2011 Jan 1;203(1):32-9. doi: 10.1093/infdis/jiq014. J Infect Dis. 2011. PMID: 21148494 Free PMC article.
-
Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom.Emerg Infect Dis. 2011 Jun;17(6):990-9. doi: 10.3201/eid/1706.101161. Emerg Infect Dis. 2011. PMID: 21749759 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous